SCHEMBL23928849

SCHEMBL23928849

CC(C)(C)OC(=O)N1CC2(CC(=O)c3ncccc3O2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 2/20 0.46
EPHX2 P34913 1/20 0.46
POLB P06746 1/20 0.45
DTYMK P23919 1/20 0.39
GPR119 Q8TDV5 6/20 0.39
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
GPR183 P32249 1/20 0.37
ACACA Q13085 1/20 0.37
GRM5 P41594 1/20 0.36
SCD5 Q86SK9 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3491735 0.90 EPHX2 (0.55) ACACBEPHX2POLBDTYMKGPR119
SCHEMBL23928898 0.82 EPHX2 (0.54) ACACBEPHX2ACACAHDAC3HDAC4
SCHEMBL23928877 0.81 ATM (0.51) EPHX2HDAC3HDAC4HDAC1HDAC7
SCHEMBL22945801 0.79 POLB (0.43) POLBDTYMKGPR119DDB1CRBN
SCHEMBL22980435 0.78 POLB (0.47) ACACBEPHX2POLBDTYMKGPR119
SCHEMBL30953771 0.78 CCNC (0.47) GPR119GPR183HDAC3HDAC4HDAC1
SCHEMBL25390075 0.76 GPR119 (0.49) ACACBEPHX2POLBDTYMKGPR119
SCHEMBL31283120 0.76 GPR119 (0.49) ACACBEPHX2POLBDTYMKGPR119
SCHEMBL22944644 0.75 GPR119 (0.43) POLBDTYMKGPR119DDB1CRBN
SCHEMBL29626721 0.74 NPC1 (0.48) POLBDTYMKGPR119DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112823157-B Spirochroman derivatives 吉瑞工厂 2024-08-09 CN disclosed
EP-3820869-B1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT (HU) 2023-08-30 EP disclosed
US-20210330650-A1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210330650-A1 SPIROCHROMANE DERIVATIVES CHRNA7, CHRM3, ADRB3 ACACB 3164/4885EPHX2 1079/4885POLB 3429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.